The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes.

[1]  C. N. Reilley,et al.  Advances in analytical chemistry and instrumentation , 1960 .

[2]  T. Higuchi,et al.  COMPLEXATION OF ORGANIC SUBSTANCES IN AQUEOUS SOLUTION BY HYDROXYAROMATIC ACIDS AND THEIR SALTS. II. INFLUENCE OF HALOGEN, NITRO, AND OTHER SUBSTITUENTS AND CORRELATION OF BINDING TENDENCIES TOWARD PREDNISOLONE, THEOPHYLLINE, AND PHENACETIN. , 1961, Journal of pharmaceutical sciences.

[3]  K. Florey,et al.  Analytical profiles of drug substances , 1972 .

[4]  R. M. Hyde,et al.  Substituent constant for drug design studies based on properties of organic electron donor--acceptor complexes. , 1978, Journal of pharmaceutical sciences.

[5]  D. Breimer,et al.  Nifedipine: Kinetics and dynamics in healthy subjects , 1984, Clinical pharmacology and therapeutics.

[6]  D. Breimer,et al.  Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system , 1984, Clinical pharmacology and therapeutics.

[7]  S. Shinkai.  Calixarenes as new functionalized host molecules , 1986 .

[8]  S. Shinkai,et al.  Hexasulfonated calix[6]arene derivatives: a new class of catalysts, surfactants, and host molecules. , 1986, Journal of the American Chemical Society.

[9]  S. Shinkai,et al.  Does the calixarene cavity recognise the size of guest molecules? On the ‘hole-size selectivity’ in water-soluble calixarenes , 1988 .

[10]  F. Diederich,et al.  Cyclophane-arene inclusion complexation in protic solvents: solvent effects versus electron donor-acceptor interactions , 1991 .

[11]  I. Warner,et al.  Cyclodextrin-induced asymmetry of achiral nitrogen heterocycles , 1992 .

[12]  J. Atwood,et al.  Double partial cone conformation for Na{sub 8}(calix[6]arene sulfonate){center_dot}20.5H{sub 2}O and its parent acid , 1992 .

[13]  G. Arena,et al.  Water soluble calix[4]arenes. A thermodynamic investigation of proton complex formation , 1992 .

[14]  I. Warner,et al.  Spectroscopic studies of water-soluble sulfonated calix[6]arene , 1996 .

[15]  B. Glass,et al.  Phase solubility analysis in studying the interaction of nifedipine with selected cyclodextrins in aqueous solution , 1996 .

[16]  I. Warner,et al.  Complexation Studies of Water-soluble Calixarenes and Auramine O Dye , 1997 .

[17]  M. Barra,et al.  Thermodynamic study of p-sulfonated calixarene complexes in aqueous solution , 1998 .

[18]  H. Sunada,et al.  Mechanistic studies on hydrotropic solubilization of nifedipine in nicotinamide solution. , 1998, Chemical & pharmaceutical bulletin.

[19]  J. Millership.  A Preliminary Investigation of the Solution Complexation of 4-Sulphonic calix[n]arenes with Testosterone , 2001 .

[20]  A. Kaifer,et al.  Temperature, solvent, proton transfer and complexation effects on the conformational flexibility of the anionic host calix[6]arenesulfonate , 2001 .

[21]  Yongjun Zhang,et al.  Self-assembly of small molecules: An approach combining electrostatic self-assembly technology with host–guest chemistry , 2001 .

[22]  K. Chowdary,et al.  Complexes Of Nifedipine With β-And Hydroxypropyl β-Cyclodextrins In The Design Of Nifedipine SR Tablets , 2002 .

[23]  K. Boje,et al.  Complexation of Nifedipine with Substituted Phenolic Ligands , 1988, Pharmaceutical Research.